Nifty IT 38991.6 (3.09)
Nifty Pharma 22419.55 (-0.38)
Nifty 50 25857.5 (0.75)
Nifty Next 50 69312.85 (0.76)
SENSEX 84051.77 (0.80)
Nifty Smallcap 100 17483.95 (0.42)
Nifty Midcap 100 60296.65 (0.88)
Nifty Bank 60143.25 (0.95)
NIKKEI 225 54048.24 (-0.12)
HANG SENG 26802.5 (-0.45)
S&P 6965.97 (0.26)
18-Nov-2021
Sales up 26%, PAT up 42%
'Standalone net sales (including other operating income) of Rajoo Engineers for the quarter ended Sep 2021 has increased 26.23% to Rs 37.01 crore. Operating profit margin has declined from 14.15% to 14.08%, leading to 25.54% rise in operating profit to Rs 5.21 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 59.15% to 62.16%. Employee cost decreased from 9.44% to 8.55%. Other expenses fell from 19.11% to 16.28%. Other income up 156.25% to Rs 0.41 crore. PBIDT rose 30.39% to Rs 5.62 crore. Provision for interest fell 63.33% to Rs 0.11 crore. PBDT rose 37.41% to Rs 5.51 crore. Fixed assets declined from Rs 41.94 crore as of 30 September 2020 to Rs 40.54 crore as of 30 September 2021. Intangible assets declined from Rs 1.69 crore to Rs 1.40 crore. Profit before tax grew 47.77% to Rs 4.64 crore. Provision for tax was...
(16-Jan-2026)
Revenue up 10% YoY to Rs 2923.5 cr in Q3FY2026
Revenue up 12% yoy to Rs 2701.3 crore in Q3FY2026
Total premium income rises 9% in Q3FY2026
(15-Jan-2026)
OP surged 39.94%
Results-Analysis (06-Nov-2025)
Net up 79% on strong operating show
Results-Analysis (01-Feb-2022)
Sales up 1%, net stayed flat
Results-Analysis (18-Nov-2021)
Analyst Meet / AGM-Conference Call (10-Aug-2021)
Khushboo C Doshi, Executive Director-MD, Sunil Jain, ED;Jayantilal T Jhalavadia, CFOand Prakash, VP Finance.